Concepedia

Author

N. Tassopoulos

Western Attica General Hospital

Also Known As

N C Tassopoulos, N TASSOPOULOS, N Tassopoulos, N. C. Tassopoulos, N. TASSOPOULOS, N. Tassopoulos, Nikolaos C. Tassopoulos

35

Publications

651

Citations

16

H-Index

38

Concepts

All Affiliations

Western Attica General HospitalNational and Kapodistrian University of AthensLaiko General Hospital of AthensNational School of Public HealthSismanoglio General Hospital
NT

About

N. Tassopoulos is an author at Western Attica General Hospital specializing in medicine, hepatology, and viral hepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

209

2

Epidemiology

2

2

37

3

Health Sciences

1

1

20

4

Public Health

1

1

20

5

Biochemistry

1

1

39

N. Tassopoulos

×

16

Publications

569

Citations

15

H-Index

YearCitations

A survey of bloodborne viruses and associated risk behaviours in Greek prisons

M. Malliori, Vana Sypsa, Giota Touloumi,

Addiction

1998

99

Fecal Excretion of Greek Strains of Hepatitis A Virus in Patients with Hepatitis A and in Experimentally Infected Chimpanzees

N. Tassopoulos, G. Papaevangelou, John R. Ticehurst,

The Journal of Infectious Diseases

1986

79

Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection

Vana Sypsa, Giota Touloumi, N. Tassopoulos,

Journal of Viral Hepatitis

2004

52

Detection of hepatitis A virus by extraction of viral RNA and molecular hybridization

John R. Ticehurst, S M Feinstone, Taylor Chestnut,

Journal of Clinical Microbiology

1987

43

Future trends of HCV‐related cirrhosis and hepatocellular carcinoma under the currently available treatments

Vana Sypsa, Giota Touloumi, George Papatheodoridis,

Journal of Viral Hepatitis

2005

39

DIVERSE CHARACTERISTICS OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE FROM GREEK CHILDREN.

Kirkman Hn, Doxiadis Sa, Timos Valaes,

PubMed

1965

39

46 Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES)

Stephanos J. Hadziyannis, N. Tassopoulos, T.T. Chang,

Journal of Hepatology

2004

36

Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.

N. Tassopoulos, M. Koutelou, George Papatheodoridis,

Gut

1993

31

Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B

Seng Gee Lim, Patrick Marcellin, N. Tassopoulos,

Alimentary Pharmacology & Therapeutics

2007

28

Factors associated with severity and disease progression in chronic hepatitis C.

N. Tassopoulos, George Papatheodoridis, A. Katsoulidou,

PubMed

1999

25

Page 1